Albumin, prealbumin and CRP levels can be used to predict prognosis in gastric cancer
DOI:
https://doi.org/10.18203/2349-2902.isj20170616Keywords:
Albumin, CRP, Gastric cancer, Pre-albuminAbstract
Background: malnutrition and systemic inflammatory response in cancers result in a shorter survival rate, reduced treatment response and a higher rate of complications associated with therapy. Prealbumin, albumin and CRP Levels has utility as a prognostic indicator of cancer survival in cancer. The objective of this study was to albumin, pre-albumin and CRP levels of the patients who underwent surgery for gastric cancer were prospectively recorded and retrospectively evaluated.
Methods: Study was done for period of 1 year in patients underwent surgery for gastric cancer. Details noted from records are as age, gender, duration of hospital stay, TNM stage, and preoperative albumin, pre-albumin and CRP levels.
Results: A total number of 44 patients, 32 (72.7%) men and 12 (27.7%) women, were included in the study. The mean age was 64.1 (43-89) years. The mean duration of hospital stay was 12.8 (4-46) days. Preoperative albumin levels were below the expected range in 16 (41%) of 44 patients. Mean age of the patients with normal and decreased albumin levels was 62.7±12.8 and 65.3±12.3 years, respectively; albumin levels were insignificantly associated with the age (p = 0.54). When these 16 cases were evaluated in terms of disease stage-3 had 11(68.7%). Preoperative pre-albumin levels were decreased in 23 (53%) of 44 cases. Among the cases with decreased pre-albumin levels, stage 1 and 3 had 5 (21.7%) cases. There was a significant correlation between the TNM stage and pre-albumin levels (P = 0.014). CRP levels were elevated in 19 (43.2%) of 44 cases with CRP. Among these Stage-3 had 8 cases, 4 (42.1%). There was no significant correlation between disease stage, presence of metastatic lymph nodes and albumin levels (p>0.05).
Conclusions: Preoperative albumin, pre-albumin and CRP levels can be useful to predict prognosis of patients with gastric cancer.
Metrics
References
Higginson IJ, Costantini M. Dying with cancer, living well with advanced cancer. Eur J Cancer. 2008;44:1414-24.
Von M. Cancer-associated malnutrition: an introduction. Eur J Oncol Nurs. 2005;9(Suppl 2):S35-38.
Dewys WD. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69:491-7.
Pan QX, Su ZJ, Zhang JH, Wang CR, Ke SY. Acomparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. Onco Targets Ther. 2005;8:1375-85.
Wang J, Ma R, Sharma A, He M, Xue J. Inflammatory serum proteins are severely altered in metastatic gastric adenocarcinoma patients from the chinese population. PloS one. 2014;10:e0123985.
Baba H, Kuwabara K, Ishiguro T, Hatano S, Matsuzawa T. C-reactive protein as a significant prognostic factor for stage IV gastric cancer patients. Antıcancer Res. 2013;33:5591-6.
Liu X, Sun X, Liu J, Kong P, Chen S. Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer. Translational Oncol. 2015;8:339-45.
Richards CH, Leitch EF, Horgan PG, Anderson JH, McKee RF. The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer. Br J Cancer. 2010;103:1356-661.
Crumley AB, Stuart RC, McKernan M, McMillan DC. Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg. 2010;34:2393-8.
Ho SY, Guo HR, Chen HH, Peng CJ. Nutritional predictors of survival in terminally ill cancer patients. J Formos Med Assoc. 2003;102:544-50.
Jiang X, Hiki N, Nunobe S, Kumagai K, Kubota T, et al. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. British J Cancer. 2012;107:275-9.
Abramovitch R, Marikovsky M, Meir G, Neeman M. Stimulation of tumour growth by wound-derived growth factors. Br J Cancer. 1999;79:1392-998.
Wakuda R, Miki C, Kusunoki M. Autoreactivity against interleukin 6 as a risk factor in elderly patients with colorectal carcinoma. Arch Surg. 2001;136:1274-9.
Gao Y, Huang D. The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: a literature review. J Cancer Res Therapeut. 2014;10:799-804.
Esfahani A, Makhdami N, Faramarzi E, Asghari Jafarabadi M, Ostadrahimi A. Prealbumin/CRP based prognostic score, a new tool for predicting metastasis in patients with inoperable gastric cancer. Gastroenterol Res Pract. 2016;4686189.
Mahlck CG, Granvist K. Plasma prealbumin in women with epithelial ovarian carcinoma. Gynecol Obstet Invest. 1994;37:135-40.
Kawai H, Ota H. Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg. 2012;36:2853-7.
Tang Z, Sheng H, Zheng X, Ying L, Wu L. Upregulation of circulating cytokeratin 20, urokinase plasminogen activator and C-reactive protein is associated with poor prognosis in gastric cancer. Mol Clin Oncol. 2015;3:1213-20.
Chen XL, Xue L, Wang W, Chen HN, Zhang WH. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget. 2015;6:41370-82.